Integrated Research (IRI.AX) Stock Price
Integrated Research Price
Over the last 19 years Integrated Research grew revenue by 3.7% annually, reaching 68.26 M AUD. Earnings per share have grown at 3.1% per year over the last 19 years. For Integrated Research, the net margin of 19.6% is up versus 10.1% a few years ago. At today's price the dividend yield works out to roughly 9.69%. The payout ratio is around 38% of earnings. The dividend has grown at 0.7% per year over the past 19 years. The consensus 12-month price target for Integrated Research is 0.41 AUD, about 38.3% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 9% above its 52-week low.
Integrated Research stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Integrated Research over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Integrated Research stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Integrated Research's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Integrated Research Price |
|---|---|
| 9/7/2026 | 0.29 AUD |
| 9/4/2026 | 0.29 AUD |
| 9/3/2026 | 0.30 AUD |
| 9/2/2026 | 0.31 AUD |
| 9/1/2026 | 0.36 AUD |
| 8/31/2026 | 0.34 AUD |
| 8/28/2026 | 0.34 AUD |
| 8/27/2026 | 0.32 AUD |
| 8/26/2026 | 0.29 AUD |
| 8/25/2026 | 0.29 AUD |
| 8/24/2026 | 0.29 AUD |
| 8/21/2026 | 0.29 AUD |
| 8/20/2026 | 0.29 AUD |
| 8/19/2026 | 0.29 AUD |
| 8/18/2026 | 0.32 AUD |
| 8/17/2026 | 0.29 AUD |
| 8/14/2026 | 0.29 AUD |
| 8/13/2026 | 0.30 AUD |
| 8/12/2026 | 0.30 AUD |
| 8/11/2026 | 0.30 AUD |
| 8/10/2026 | 0.31 AUD |
| 8/7/2026 | 0.30 AUD |
| 8/6/2026 | 0.30 AUD |
| 8/5/2026 | 0.30 AUD |
| 8/4/2026 | 0.29 AUD |
| 8/3/2026 | 0.30 AUD |
| 7/31/2026 | 0.29 AUD |
| 7/30/2026 | 0.30 AUD |
| 7/29/2026 | 0.29 AUD |
| 7/28/2026 | 0.29 AUD |
Integrated Research Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Integrated Research Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.AUD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.00 | 53.00 | 70.00 | 84.00 | 91.00 | 91.00 | 100.00 | 110.00 | 78.00 | 62.00 | 69.00 | 83.00 | 68.00 | 56.00 | 65.00 | 70.00 |
| – | 10.42 | 32.08 | 20.00 | 8.33 | – | 9.89 | 10.00 | -29.09 | -20.51 | 11.29 | 20.29 | -18.07 | -17.65 | 16.07 | 7.69 |
| 143.75 | 130.19 | 98.57 | 82.14 | 75.82 | 75.82 | 69.00 | 62.73 | 100.00 | 100.00 | 100.00 | 83.13 | 101.47 | 100.00 | 100.00 | 100.00 |
| 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | 69.00 | 78.00 | 62.00 | 69.00 | 69.00 | 69.00 | 56.00 | 65.00 | 70.00 |
| 10.00 | 10.00 | 17.00 | 21.00 | 27.00 | 25.00 | 27.00 | 32.00 | 9.00 | -7.00 | – | 25.00 | 13.00 | 4.00 | 5.00 | 5.00 |
| 20.83 | 18.87 | 24.29 | 25.00 | 29.67 | 27.47 | 27.00 | 29.09 | 11.54 | -11.29 | – | 30.12 | 19.12 | 7.14 | 7.69 | 7.14 |
| 9.00 | 8.00 | 14.00 | 16.00 | 18.00 | 19.00 | 21.00 | 24.00 | 7.00 | 1.00 | -29.00 | 27.00 | 13.00 | – | 3.00 | 4.00 |
| – | -11.11 | 75.00 | 14.29 | 12.50 | 5.56 | 10.53 | 14.29 | -70.83 | -85.71 | -3,000.00 | -193.10 | -51.85 | – | – | 33.33 |
| 0.06 | 0.06 | 0.09 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | – | – | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| – | – | 50.00 | -11.11 | 12.50 | – | 11.11 | – | 10.00 | – | – | – | – | – | – | – |
| 169.70 | 169.90 | 170.92 | 171.65 | 171.76 | 172.07 | 172.11 | 172.53 | 172.60 | 172.89 | 172.90 | 178.76 | 176.76 | 176.76 | 176.76 | 176.76 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Integrated Research generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Integrated Research retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Integrated Research's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Integrated Research has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Integrated Research's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Integrated Research stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Integrated Research Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Integrated Research business model & stock analysis
Integrated Research SWOT Analysis
Strengths
- Integrated Research Ltd is a leading provider of performance management software solutions
- The company has a strong and diverse customer base including major corporations across various industries
- Integrated Research has a proven track record of delivering high-quality products and services
- The company has a global presence with offices and customers in multiple regions
- Integrated Research has a strong financial position and a history of consistent revenue growth
Weaknesses
- The company is highly dependent on key customers, and a loss of any major contract could impact revenue
- Integrated Research faces intense competition in the performance management software market
- The company's success depends on its ability to continuously innovate and keep up with rapidly evolving technology
- Integrated Research may face challenges in expanding into new markets and attracting new customers
Opportunities
- There is a growing demand for performance management software as organizations strive to optimize their operations and improve efficiency
- Integrated Research can capitalize on the increasing adoption of cloud-based solutions
- The company can explore partnership opportunities with other software providers to enhance its product offerings
- Integrated Research can expand its presence in emerging markets where there is a potential for significant growth
Threats
- The performance management software market is highly competitive, and new entrants can pose a threat to Integrated Research's market share
- Technological advancements and changing customer preferences may require the company to adapt and invest in research and development
- Economic downturns could lead to reduced spending on software solutions, impacting Integrated Research's revenue
- Political and regulatory changes in different regions may affect the company's ability to operate and expand internationally
Integrated Research Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Integrated Research historical P/E ratio, EBIT multiple, and P/S ratio
Integrated Research annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Integrated Research shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Integrated Research Dividend History
23 years of dividend payments
Integrated Research dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Integrated Research dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Integrated Research forecasts and price targets in September 2026
Analyst Price Targets 2026Integrated Research Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 2/12/2009 | 0.02AUD | - | 22.33 MAUD | - | 2009 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Integrated Research stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Integrated Research shareholder structure
| % | Name |
|---|---|
0.89267% | |
0.00000% | |
0.00000% |
Integrated Research Executives and Management Board
8 members · 25 % women
Mr. Christian Shaw
Chief Financial Officer
230,486.00 AUD
Management
Mr. Ian Lowe
Chief Executive Officer, Managing Director
Mr. William Witherow
General Counsel
Ms. Leanne Ralph
Company Secretary
Board of Directors
Mr. Peter Lloyd
Independent Non-Executive Chairman of the Board
Mr. Michael Hitz
Independent Non-Executive Director
Mr. Mark Brayan
Non-Executive Independent Director · since 2007
Ms. Katherine Greenhill
Non-Executive Independent Director
Integrated Research Supply Chain
Integrated Research Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.70 | 0.90 | 0.78 | ||
| 2 | 0.95 | 0.96 | 0.70 | ||
| 3 | 0.79 | 0.92 | 0.41 | ||
| 4 | 0.91 | 0.73 | 0.33 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.03 | -0.86 | -0.91 | ||
| 2 | -0.04 | -0.69 | -0.87 | ||
| 3 | 0.88 | -0.32 | -0.87 | ||
| 4 | -0.70 | -0.19 | -0.85 | ||
| 5 | -0.81 | -0.84 | -0.82 |
Frequently asked questions about Integrated Research
Integrated Research Ltd (IRL) is an Australian-based software company specializing in performance management and critical business communication solutions. IRL's business model revolves around developing and delivering innovative software solutions that help organizations optimize and manage their critical IT infrastructure, communications, and payments. By offering a comprehensive suite of products, including Prognosis, IR Collaborate, and Payments Notification, IRL enables businesses to proactively monitor, measure, and enhance the performance of their mission-critical systems and applications. IRL's business model focuses on providing reliable and effective solutions that drive operational efficiency, increase customer satisfaction, and ensure smooth, uninterrupted business operations.
Integrated Research Ltd (IR) is primarily active in the software and technology industry. As a global provider of proactive performance management software, IR serves various sectors including banking and financial services, telecommunications, government, and healthcare. With its innovative solutions, IR helps organizations enhance their operational efficiency, resolve critical system issues, and maintain optimal performance across their networks.
Integrated Research Ltd faces competition from multiple companies in the market. Some of its main competitors include NICE Ltd, Verint Systems Inc, and CA Technologies. These companies also offer software solutions and services for business performance, customer experience management, and collaboration. Integrated Research differentiates itself through its innovative and comprehensive approach to monitoring and managing critical IT infrastructure and applications. With its strong market presence and reputation in the industry, Integrated Research continues to face competition but remains a leading player in the market.
Integrated Research Ltd is an Australian company that specializes in developing and providing performance management software solutions. Founded in 1988, Integrated Research has grown to become a leading global provider of monitoring, diagnostics, and business process automation solutions. The company's flagship product, Prognosis, offers real-time insights into critical IT infrastructure and business processes, allowing organizations to optimize performance, enhance customer experiences, and improve operational efficiency. With a strong focus on innovation and strategic partnerships, Integrated Research continues to expand its global presence and deliver cutting-edge solutions to help businesses across various industries achieve their performance goals.
Some significant milestones achieved by Integrated Research Ltd include becoming a publicly listed company on the Australian Stock Exchange in 2000, expanding its global presence with offices in North America, Europe, and Asia, and consistently delivering strong financial performance with steady revenue growth. The company has also forged strategic partnerships with major technology providers, enabling it to develop innovative and industry-leading solutions. Integrated Research Ltd has received multiple prestigious industry awards, acknowledging its commitment to delivering excellence in performance management and monitoring solutions for business-critical environments. These achievements demonstrate the company's continuous growth, market recognition, and dedication to providing cutting-edge solutions for its clients.
Integrated Research Ltd is primarily present in various countries and regions around the world. The company's presence can be found in Australia, North America, Europe, Asia-Pacific, and Latin America. With a global footprint, Integrated Research Ltd has established a strong presence in these regions, delivering its innovative solutions and services to customers worldwide.
Integrated Research Ltd represents a strong commitment to innovation, excellence, and customer satisfaction. The company's corporate philosophy centers around delivering world-class software solutions and services that empower businesses to optimize their performance and ensure superior customer experiences. Integrated Research Ltd focuses on leveraging cutting-edge technologies and industry expertise to deliver actionable insights and intelligent automation. With a customer-centric approach, the company aims to build long-term partnerships and provide comprehensive support to meet the unique needs of its clients. In essence, Integrated Research Ltd stands for a dedication to success, leadership in technology, and delivering value to its stakeholders.
Analysts currently set an average price target of 0.41 AUD for the Integrated Research stock (median: 0.41 AUD), implying +38.3 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Integrated Research stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Integrated Research to generate revenue of 56.90 M AUD and earnings per share of -0.00 AUD.
Converted at the current exchange rate, the Integrated Research share trades at 0.18 EUR (0.29 AUD).
The Integrated Research share (IRI.AX) is listed on 2 stock exchanges, including: ASX (IRI.AX).
Integrated Research Ltd is an IT company specializing in monitoring and managing business applications to ensure smooth business operations. Founded in 1988 and headquartered in Sydney, Australia, Integrated Research Ltd offers a wide range of solutions for IT infrastructure, communication, and collaboration for businesses. Its business model is based on three main divisions: forecasting and performance analytics, unified communications monitoring, and network management. Each division offers different products and services to help companies effectively manage their IT infrastructure. Overall, Integrated Research Ltd aims to support companies in effectively managing their IT infrastructure and ensuring seamless business operations.
The expected revenue of Integrated Research is 56.90 M AUD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Integrated Research is -176,757.22 AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Integrated Research is currently -295.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Integrated Research stock.
The price-to-sales ratio (P/S) of Integrated Research is currently 0.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Integrated Research stock.
The Eulerpool Quality Score for Integrated Research is 2/10.
The ISIN of Integrated Research is AU000000IRI3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Integrated Research is IRI.AX. The ticker symbol is used to trade Integrated Research shares on the stock exchange.
Over the past 12 months, Integrated Research paid a dividend of 0.03 AUD . This corresponds to a dividend yield of about 9.69 %. For the coming 12 months, Integrated Research is expected to pay a dividend of 0.03 AUD.
The current dividend yield of Integrated Research is 9.69 %.
Integrated Research pays a dividend, distributed in the months of , , , .
Integrated Research paid dividends every year for the past 2 years.
For the upcoming 12 months, dividends amounting to 0.03 AUD are expected. This corresponds to a dividend yield of 9.69 %.
Integrated Research is assigned to the 'Information technology' sector.
To receive the latest dividend of Integrated Research from amounting to 0.03 AUD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
The dividends of Integrated Research are distributed in AUD.
Integrated Research stock
Integrated Research Peer Group
Integrated Research Ticker
Integrated Research FIGI
All fundamentals and in-depth analysis of Integrated Research
Our stock analysis for Integrated Research stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integrated Research. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.